申请人:Merck & Co. Inc.
公开号:US05670504A1
公开(公告)日:1997-09-23
A class of 2,6-diarylpyridazinones of general structural formula I have been identified that exhibit exhibit immunosuppressant activity with human T-lymphocytes, and are useful as an immunosuppressants. ##STR1## or a pharmaceutically acceptable salt, hydrate or crystal form thereof
已经确定了一类具有一般结构式I的2,6-二芳基吡啶并酮,其表现出对人类T淋巴细胞的免疫抑制活性,并且可用作免疫抑制剂。##STR1##或其药用可接受的盐、水合物或晶体形式